Back to catalog
HealingModerate evidence

BPC-157

Body protection compound studied for regenerative and gut-healing properties. Evidence is extensive in animal models; human clinical data remain limited.

Half-life
Short (model-dependent)
Administration
Research protocols vary (injectable / oral formulations)
Primary uses
Soft-tissue recovery · Gut lining support · Tendon research

Mechanism

Proposed angiogenic and cytoprotective effects via nitric-oxide and growth-factor pathways; research focuses on tendon, muscle, and GI mucosa recovery.

  • Soft-tissue recovery
  • Gut lining support
  • Tendon research

Dosing ranges

Educational ranges only — not medical advice. Confirm protocols with a qualified clinician.

Use caseTypical rangeFrequencyNotes
Research soft-tissue protocols250–500 mcg1–2× dailyCommon research ranges only — not medical advice

Clinical evidence

Moderate evidence
J Orthop Res (review of animal data) · 2019

Gastric pentadecapeptide BPC 157 and wound healing

Consistent regenerative signals across tendon and muscle injury models.

Cautions

  • Not FDA-approved for therapeutic use
  • Human RCTs are sparse
  • Source quality varies widely outside clinical channels

Provider comparison

Affiliate-style comparison cards for clinics, telehealth, and research suppliers. Verify licensing and product quality before purchasing.

Fountain Health
telehealth
4.7
From $249/mo

Licensed clinician consult + ongoing titration support

Compare offer
PeakRx Clinic
clinic
4.5
From $189/mo

In-person labs available in select metros

Compare offer
Research Supply Co.
research
4.1
Vial pricing

Research-only sourcing — not for human consumption labeling

View listing
Healing
Emerging evidence

TB-500

Thymosin beta-4 fragment associated with wound healing, cell migration, and tissue repair in preclinical literature.

Injury recovery researchView research →